The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours.

作者: M. Takemoto , M. Kuroda , M. Urano , Y. Nishimura , S. Kawasaki

DOI: 10.1080/0265673021000035235

关键词: MelphalanCisplatinPathologyCyclophosphamideChemotherapyMedicineChemosensitizing agentIfosfamideCancer researchMitomycin CHyperthermia

摘要: It has been shown that hyperthermia can enhance the cytotoxicity of some chemotherapeutics. However, most effective agent(s) at elevated temperatures have yet to be determined. A previous study suggests drug choice may different from physiological temperature, and alkylating agents temperatures. To further investigate these possibilities, effect chemotherapeutic were compared. These cyclophosphamide, ifosfamide, melphalan, cis-diamminedichloroplatinum (II), 5-fluorouracil, mitomycin C bleomycin. Three tumours (mammary carcinoma, osteosarcoma squamous cell carcinoma) used. They transplanted into feet C3H/He mice. When reached 65 mm(3), a test agent was injected intraperitoneally. Tumours immediately heated 41.5 degrees for 30 min, tumour growth (TG) time studied each tumour. Using TG times, TG-50 (the required one-half total number treated reach volume 800 mm(3) mm(3)) calculated. Subsequently, delay (GDT) thermal enhancement ratio (TER) obtained. The GDT difference between non-treated control tumours. TER group with an room temperature. Results showed top three tested solely agents--CY, IFO L-PAM--for kind cisplatin smaller than those agents. smallest TER, 1.1, observed which given mammary C, carcinoma. could concluded might drugs many types possible mechanisms associated are discussed.

参考文章(33)
Jane B. Marmor, Interactions of Hyperthermia and Chemotherapy in Animals Cancer Research. ,vol. 39, pp. 2269- 2276 ,(1979)
A M Eggermont, H Schraffordt Koops, D Liénard, B B Kroon, A N van Geel, H J Hoekstra, F J Lejeune, Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. Journal of Clinical Oncology. ,vol. 14, pp. 2653- 2665 ,(1996) , 10.1200/JCO.1996.14.10.2653
H. Richard Alexander, Douglas L. Fraker, David L. Bartlett, ISOLATED LIMB PERFUSION FOR MALIGNANT MELANOMA Seminars in Surgical Oncology. ,vol. 12, pp. 416- 428 ,(1996) , 10.1002/(SICI)1098-2388(199611/12)12:6<416::AID-SSU7>3.0.CO;2-D
M. Urano, J. Begley, R. Reynolds, Interaction between adriamycin cytotoxicity and hyperthermia: growth-phase-dependent thermal sensitization. International Journal of Hyperthermia. ,vol. 10, pp. 817- 826 ,(1994) , 10.3109/02656739409012374
E. Reed, R. F. Ozols, R. Tarone, S. H. Yuspa, M. C. Poirier, Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 5024- 5028 ,(1987) , 10.1073/PNAS.84.14.5024
G�nter Wiedemann, Stefan Roszinski, Anke Biersack, Christoph Weiss, Thomas Wagner, Local hyperthermia enhances cyclophosphamide, ifosfamide and cis-diamminedichloroplatinum cytotoxicity on human-derived breast carcinoma and sarcoma xenografts in nude mice. Journal of Cancer Research and Clinical Oncology. ,vol. 118, pp. 129- 135 ,(1992) , 10.1007/BF01187501
M. Kuroda, M. Urano, R. Reynolds, Thermal enhancement of the effect of ifosfamide against a spontaneous murine fibrosarcoma, FSa-II. International Journal of Hyperthermia. ,vol. 13, pp. 125- 131 ,(1997) , 10.3109/02656739709056436
Jacob chr Lindegaard, Marko Radacic, Azza A Khalil, Michael R Horsman, Jens Overgaard, None, Cisplatin and hyperthermia treatment of a C3H mammary carcinoma in vivo. Importance of sequence, interval, drug dose, and temperature. Acta Oncologica. ,vol. 31, pp. 347- 351 ,(1992) , 10.3109/02841869209108184
M. URANO, For the clinical application of thermochemotherapy given at mild temperatures. International Journal of Hyperthermia. ,vol. 15, pp. 79- 107 ,(1999) , 10.1080/026567399285765